4.7 Review

Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies

Umar Hayat et al.

Summary: Regular coffee consumption is significantly associated with a reduced risk of NAFLD and liver fibrosis development, benefiting liver health. However, further epidemiological studies are needed to confirm this conclusion.

ANNALS OF HEPATOLOGY (2021)

Article Medicine, General & Internal

Relationship between coffee consumption, sleep duration and smoking status with elastographic parameters of liver steatosis and fibrosis; controlled attenuation parameter and liver stiffness measurements

Ivana Mikolasevic et al.

Summary: The study demonstrates that frequent coffee consumption is associated with lower risk of obesity, hypertension, dyslipidemia, and diabetes, as well as significantly lower values of CAP and LSM. Moderate sleep duration is also related to lower CAP and LSM values, while smoking status has no association with CAP or LSM values.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Review Gastroenterology & Hepatology

NASH/Liver Fibrosis Prevalence and Incidence of Nonliver Comorbidities among People with NAFLD and Incidence of NAFLD by Metabolic Comorbidities: Lessons from South Korea

Jiyoon Park et al.

Summary: A meta-analysis on the Korean population revealed a high prevalence of NAFLD, especially among those with metabolic risks. The risk of developing type 2 diabetes, hypertension, cardiovascular disease, and chronic kidney disease was also found to be relatively high in the NAFLD population.

DIGESTIVE DISEASES (2021)

Article Gastroenterology & Hepatology

The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995-2040

Takanori Ito et al.

Summary: The prevalence of NAFLD in Japan is around 25.5%, with a higher incidence in males and a predicted increase to affect half of the population by 2040. Lean NAFLD individuals make up around 20% of the NAFLD population, with older age and higher mortality rates.

HEPATOLOGY INTERNATIONAL (2021)

Article Gastroenterology & Hepatology

Economic burden of non-alcoholic steatohepatitis with significant fibrosis in Thailand

Pochamana Phisalprapa et al.

Summary: The study estimated the economic burden of NASH in Thailand, finding that the total lifetime cost of significant NASH is substantial, prompting clinicians and policy makers to consider strategies for NASH prevention and management.

BMC GASTROENTEROLOGY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Editorial Material Gastroenterology & Hepatology

Redefining non-alcoholic fatty liver disease: what's in a name?

[Anonymous]

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Review Medicine, General & Internal

Nonalcoholic Fatty Liver Disease: A Challenge from Mechanisms to Therapy

Giovanni Tarantino et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Gastroenterology & Hepatology

Modelling the economic and clinical burden of non-alcoholic steatohepatitis in East Asia: Data from Hong Kong

Radhika P. Tampi et al.

HEPATOLOGY RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

The increased amount of coffee consumption lowers the incidence of fatty liver disease in Korean men

Hye-Kyung Chung et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2020)

Article Gastroenterology & Hepatology

Burden of Illness and Economic Model for Patients With Nonalcoholic Steatohepatitis in the United States

Zobair M. Younossi et al.

HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

Simona Leoni et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis

Karn Wijarnpreecha et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study

Louise J. M. Alferink et al.

JOURNAL OF HEPATOLOGY (2017)

Letter Gastroenterology & Hepatology

Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort

Veronica Wendy Setiawan et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

Article Medical Laboratory Technology

Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population

Shira Zelber-Sagi et al.

TRANSLATIONAL RESEARCH (2015)

Article Health Care Sciences & Services

Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach

Edoardo Aromataris et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

Article Public, Environmental & Occupational Health

Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review

Raul Herzog et al.

BMC PUBLIC HEALTH (2013)

Article Gastroenterology & Hepatology

Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model

Sung Gon Shim et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Caffeine is protective in patients with non-alcoholic fatty liver disease

A. Birerdinc et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)

Article Pharmacology & Pharmacy

Coffee and Caffeine Protect against Liver Injury Induced by Thioacetamide in Male Wistar Rats

Kelly S. Furtado et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2012)

Article Gastroenterology & Hepatology

Protective Role of Coffee in Non-alcoholic Fatty Liver Disease (NAFLD)

Daniela Catalano et al.

DIGESTIVE DISEASES AND SCIENCES (2010)